NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球HELLP症候群市場(2020年∼2027年)

Global HELLP Syndrome Market - 2020-2027

出版商 DataM Intelligence 商品編碼 1003508
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
全球HELLP症候群市場(2020年∼2027年) Global HELLP Syndrome Market - 2020-2027
出版日期: 2021年05月04日內容資訊: 英文 180 Pages
簡介

妊娠相關並發症發生率的增加,加上診斷試劑盒的最新發展,預計將推動市場增長。此外,患者和醫療保健提供者對包括妊娠毒血症在內的健康狀況嚴重性的認識不斷提高,將進一步提高全球對 HELLP 綜合徵的需求。以合理的價格輕鬆獲得有效資源,例如妊娠毒血症試劑和其他產品,預計將在預測期內推動 HELLP 綜合徵市場的滲透。

本報告提供全球HELLP症候群市場調查,彙整市場概要,各市場區隔(類型·用途)·各地區的市場規模及成長率的變化與預測,市場成長的推動要素及阻礙因素分析,市場機會,價格及貿易趨勢,競爭情形,主要企業簡介等資訊。

目錄

第1章 調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 市場定義和概要

第3章 摘要整理

  • 市場明細:各類型
  • 市場明細:各產品類型
  • 市場明細:各用途
  • 市場明細:各地區

第4章 市場動態

  • 市場影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求
  • 專利趨勢

第6章 新型冠狀病毒感染疾病(COVID-19)分析

  • 新型冠狀病毒感染疾病(COVID-19)的影響分析
    • COVID-19前的市場方案
    • 目前市場方案
    • COVID-19後的市場方案
  • COVID-19疫情中的價格趨勢
  • 供需頻譜
  • 疫情期間與市場相關的政府措施
  • 製造商策略性措施
  • 總論

第7章 全球HELLP症候群市場:各類型

  • 簡介
  • 市場規模·與前一年同期比較成長率分析:各類型
  • 市場魅力指數:各類型
    • 部分HELLP症候群(標準的HELLP症候群)
    • 完全HELLP症候群(標準的HELLP症候群)

第8章 全球HELLP症候群市場:各產品類型

  • 簡介
  • 市場規模·與前一年同期比較成長率分析:各產品類型
  • 市場魅力指數:各產品類型
    • 設備
    • 消耗品·試劑

第9章 全球HELPP症候群市場:各用途

  • 簡介
  • 市場規模·與前一年同期比較成長率分析:各用途
  • 市場魅力指數:各用途
    • 醫院
    • 專門診所
    • 診斷中心
    • 其他

第10章 全球HELLP症候群市場:各地區

  • 簡介
  • 市場規模分析·與前一年同期比較成長率:各地區
  • 市場魅力指數:各地區
  • 北美
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各產品類型
    • 市場規模·與前一年同期比較成長率:各用途
    • 市場規模·與前一年同期比較成長率:各國
  • 歐洲
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各產品類型
    • 市場規模·與前一年同期比較成長率:各用途
    • 市場規模·與前一年同期比較成長率:各國
  • 南美
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各產品類型
    • 市場規模·與前一年同期比較成長率:各用途
    • 市場規模·與前一年同期比較成長率:各國
  • 亞太地區
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各產品類型
    • 市場規模·與前一年同期比較成長率:各用途
    • 市場規模·與前一年同期比較成長率:各國
  • 中東·非洲
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各產品類型
    • 市場規模·與前一年同期比較成長率:各用途
    • 市場規模·與前一年同期比較成長率:各國

第11章 競爭情形

  • 競爭模式
  • 市場定位/股票分析
  • 合併·收購分析

第12章 企業簡介

  • Roche
    • 企業概要
    • 產品系列
    • 主要的焦點
    • 財務形勢
  • PerkinElmer Inc.
  • DRG Instruments GmbH
  • DiabetOmics, Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Sera Prognostics, Inc.
  • Shuwen Biotech Co. Ltd.
  • Metabolomic Diagnostics Ltd.
  • 其他的企業

第13章 重要考察

第14章 關於DataM Intelligence

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Overview

HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome is a rare life-threatening disorder commonly related to preeclampsia and eclampsia. It further causes issues with the liver, bleeding, and blood pressure. It is widely used in the healthcare sector to diagnose blood pressure measurement, red blood cell count, blood tests for an enzyme that reveal cell damage, urine test for protein, and more. Blood testing and urine analysis are the standard tests used to diagnosis the condition of HELLP syndrome. The condition usually affects the female population during pregnancies and may significantly after the infant is delivered. Perhaps, it often the greater risk of complication from premature delivery of babies when the women develop HELLP syndrome. As such, the need for HELLP syndrome treatment is gaining significant momentum in recent years to mitigate such risks associated with the disorder.

The global HELLP syndrome market size was worth US$ XX billion in 2020 and further predicted to reach US$ XX billion by 2027, at a CAGR of XX% during the forecast period (2020-2027).

Market Dynamics

The growth in incidence of pregnancy-associated complications coupled with the recent developments in diagnostics kits is expected to propel the market growth. Furthermore, the rising awareness among patients and healthcare providers for the severity of health conditions, including preeclampsia, will further enhance the HELLP syndrome demand globally. The easy accessibility of effective resources at a reasonable price, such as preeclampsia reagents and other products, is expected to fuel the penetration of the HELLP syndrome market during the forecast period.

Rising incidences of pre-eclampsia around the world

In the recent market scenario, pre-eclampsia is a staple to develop HELLP syndromes in many women worldwide, which is strengthening the demand for HELLP syndrome treatment, as it may create blood clotting problems and placenta & liver problems among women and infant during pregnancies. Along with this, the rising perinatal and maternal morbidity & mortality rate is setting to promote the need for the early diagnosis of pre-eclampsia among pregnant women globally. Moreover, the prevalence of pre-eclampsia, a precursor to eclampsia, differs greatly around the world. According to the World Health Organization (WHO) predicts that the incidence of pre-eclampsia is to be seven times higher in emerging countries (almost 2.8% of live births) than occurred in developed countries (roughly 0.4%). Similarly, according to the American Heart Association, pre-eclampsia affects between 5% to 7% of all pregnant women; however, it is liable for more than 70,000 maternal deaths and 500,000 fetal deaths worldwide each year. Therefore, the rising cases of preeclmapsia among pregnant women globally and increasing the cases of infant mortalities due to developed HELLP syndrome in mothers enhances the utility for HELLP syndrome. Furthermore, a blood test is becoming more popular than a urine test, with advancements in the product technology for diagnosing pre-eclampsia has also been a significant factor for boosting the need for HELLP syndrome treatment in the global market throughout the forecast period.

Rapid growth in pregnancy products consumption in the Asia Pacific

As per the recent demographic condition, the growth in consumption of pregnancy products based on the development of HELLP syndrome among mothers is rapidly increasing in the Asia Pacific region, owing to an increase in the purchasing power and growing prevalence of pregnancy complications among the population. The demand is also enhanced due to its enhanced utilization in HELLP syndrome treatment to meet the unmet medical needs among women and further replace traditional medication solutions.

In addition, widening HELLP syndrome market opportunities is primarily due to the surging pregnancies in Asian countries are further reinforced the product demand in the Asia-Pacific region. Healthcare sector growth in the Asian economy is feasible due to improving healthcare infrastructure, increased hospital and diagnostic centre projects, and rising target populations. Supplementary driving factors to industry growth include changing women preferences towards hygienic products to mitigate the risk of pregnancy-based health complication, which further promoting the consumption of pregnancy products, which, in turn, driving the market growth during the forecast period.

COVID-19 Impact Analysis

COVID-19 pandemic has affected the global economy in several terms, such as directly impacting the production and demand, supply chain disruption, and financial impact. With the COVID-19 disruptions in various sectors, the manufacturers' supply chain in the healthcare sector has significantly improved on a global scale to control the spread of novel coronavirus diseases. However, the ongoing pandemic further resulted in shutting down the production facilities to minimize the risk of virus spread. Also, the lockdown policies have strengthened the demand for home setting healthcare products throughout the world to meet high unmet medical needs among patients, particularly pregnant women. Therefore, the manufacturers are keen to invest and expand their production capabilities to meet the global market's updated demand. Despite the pandemic, there is growth in the overall healthcare products, which is expected to drive the HELLP syndrome's market size in the global market during the forecast period.

Segment Analysis

Based on the product type, the HELLP syndrome market has been classified into isntument and consumable

Consumables segment accounted for the highest market share in the global market

In 2019, the consumable products segment was anticipated to account for the largest share, owing to the rise in availability of reagents and kits by numerous market players, along with better treatment outcomes. Such products often help treat HELLP syndromes, as they are efficient for the rapid detection of biomarkers indicating preeclampsia. Moreover, the increasing number of pregnancy complications due to growing pregnancies in developed and developing economies is paving the growth of the consumables segment in the global HELLP syndrome market during the forecast period.

Moreover, the instruments are highly fragile and deliver fast screening tests for the biochemical markers for the treatment of HELLP syndrome. These inherent traits possessed by the instruments may result in the creation of significant growth prospect for the HELLP syndrome-based instruments market.

Based on the application, the HELLP syndrome market has been classified into hospitals, specialty clinics, diagnostic centers, and others.

Diagnostic Centers segment dominated the global HELLP syndrome market in 2019

In 2019, the diagnostic centers segment dominated the HELLP syndrome market, owing to the rising presence of advanced diagnostic instruments at these centers, and thus is the viable and efficient choice for the HELLP syndrome diagnosis. It is also expected that the diagnostic centers application is expected to grow with a significant CAGR during the forecast period, owing to they provide precise detection of HELLP syndrome development at the initial stage.

The hospital segment is expected to account for the second-largest market share, followed by specialty clinics. The hospital segment is predicted to register the second-highest CAGR throughout the forecast period, owing to its increasing rate of hospitalization coupled with growing funding and investments in hospital infrastructure projects. For instance, as per the Agency for Healthcare Research and Quality (AHRQ), around 176,925 cases of deliveries performed at hospitalization settings in 2017 across the U.S. Therefore, it is estimated to be a potential in the hospital-based diagnosis of HELLP Syndrome market.

Geographical Analysis

Based on geography, the study analyzes the HELLP syndrome market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America leads the global market throughout the forecast period.

North America dominates the global HELLP syndrome market in terms of value and volume due to the presence of leading manufacturing companies and easy accessibility of high-quality HELLP syndrome treatment products for healthcare facilities. It is also leading due to the growing complications in pregnancies or childbirth in the United States and other countries. While in Europe, the rising concern and high awareness for health-conscious disorders, along with the significant number of pregnancy failure case, will further enhance its market position in the global HELLP syndrome market in the coming years.

The Asia Pacific is estimated to grow at the HELLP syndrome market's highest growth rate during the forecast period. The growth of the region is attributing to the increasing number of pregnancy-related disorder on account of the growing female population coupled with improving healthcare infrastructure and facilities in the region. Also, the global companies are investing a substantial amount of funds to increase the export from the low-cost area, which is further likely to increase the HELLP syndrome diagnostic products in the domestic region during the forecast period.

Competitive Landscape

The HELLP syndrome market is highly competitive, owing to the presence of big healthcare brands. The key HELLP syndrome players which are contributing to the growth of the global market include Roche, PerkinElmer Inc., DRG Instruments GmBH, DiabetOmics, Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Sera Prognostics, Inc., Shuwen Biotech Co. Ltd., Metabolomic Diagnostics Ltd., among others. The major players are adopting new product launch and expansion strategies for global growth in the HELLP syndrome market.

Siemens Healthineers

Overview: Siemens Healthineers AG (formerly Siemens Healthcare, Siemens Medical Solutions, and Siemens Medical System) is a medical technology company headquartered in Germany. The company dedicated to providing various healthcare products, particularly medical diagnostics solutions, healthcare equipment, and related services. Additionally, the company offers a broad range of products for several clinical specialties and diseases, such as oncology, cardiology, neurology, surgery, allergy & anemia, autoimmune disorders, women's health, bone metabolism and so on. Further, Siemens Healthineers is rapidly developing its product and service portfolio, with AI-driven applications and digital offerings that play a prominent role in shaping the future of healthcare. Moreover, it is present in more than 70 countries in the world, serving customized products and services to meet the needs of the local market, aiding from unsurpassed global expertise.

Product Portfolio: The company's portfolio for HELLP syndrome includes hemostasis assay ranges from standard PT and APTT testing to the breakthrough von Willebrand factor activity-testing technology in INNOVANCE VWF Ac Assay. Further, it recently launched a ready-to-use liquid INNOVANCE Heparin assay and new LOC assays, which further enhanced its portfolio by streamlining workflow and allowing labs to stay on the cutting-edge clinical innovations in hemostasis testing.

Why Purchase the Report?

  • Visualize the HELLP syndrome market segmentation composition by type, product type, application, and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the HELLP syndrome market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of HELLP syndrome market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players.

The global HELLP syndrome market report would provide access to an approx. 52 market data table, 51 figures and 270 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global HELLP Syndrome Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global HELLP Syndrome Market - Market Definition and Overview

3. Global HELLP Syndrome Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Product Type
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by Region

4. Global HELLP Syndrome Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in prevalence of pregnancy associated complications cases and recent developments in diagnostics kits.
      • 4.1.1.2. Rapid increase in investments for the development of healthcare facilities
      • 4.1.1.3. Growing awareness among healthcare providers and patients about the severity of health
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness concerning the preeclampsia treatment and available diagnostic tools in developing economies.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global HELLP Syndrome Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. Global HELLP Syndrome Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global HELLP Syndrome Market - By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Partial HELLP syndrome (PHS)
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Complete HELLP Syndrome

8. Global HELLP Syndrome Market - By Product Type

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  • 8.3. Market Attractiveness Index, By Product Type Segment
    • 8.3.1. Instruments
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Consumables & Reagents

9. Global HELLP Syndrome Market - By Application

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 9.3. Market Attractiveness Index, By Application Segment
    • 9.3.1. Hospitals
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Specialty Clinics
    • 9.3.3. Diagnostic Centers
    • 9.3.4. Others

10. Global HELLP Syndrome Market - By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Global HELLP Syndrome Market - Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Global HELLP Syndrome Market- Company Profiles

  • 12.1. Roche
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. PerkinElmer Inc.
  • 12.3. DRG Instruments GmbH
  • 12.4. DiabetOmics, Inc.
  • 12.5. Siemens Healthineers
  • 12.6. Thermo Fisher Scientific Inc.
  • 12.7. Sera Prognostics, Inc.
  • 12.8. Shuwen Biotech Co. Ltd.
  • 12.9. Metabolomic Diagnostics Ltd.
  • 12.10. Others

LIST NOT EXHAUSTIVE

13. Global HELLP Syndrome Market - Premium Insights

14. Global HELLP Syndrome Market - DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us